NPI: 1619203791 · CHARLOTTE, NC 28216 · Pediatrics Physician · NPI assigned 10/26/2009
Authorized official LAYMON, THOMAS controls 20+ related entities in our dataset. Read more
| Authorized Official | LAYMON, THOMAS (SENIOR VICE PRESIDENT) |
| Parent Organization | SOUTH LAKE PEDIATRICS |
| NPI Enumeration Date | 10/26/2009 |
Other providers sharing the same authorized official: LAYMON, THOMAS
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 14,684 | $430K |
| 2019 | 12,986 | $497K |
| 2020 | 12,022 | $449K |
| 2021 | 37,926 | $325K |
| 2022 | 23,728 | $112K |
| 2023 | 25,923 | $114K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99199 | Unlisted special service, procedure or report | 86,878 | 67,670 | $529K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 6,258 | 5,691 | $362K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 2,917 | 2,403 | $229K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 2,694 | 2,387 | $215K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2,554 | 2,270 | $213K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 3,531 | 3,191 | $125K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 5,514 | 4,935 | $101K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 786 | 731 | $70K |
| 90474 | 786 | 704 | $14K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,831 | 1,693 | $13K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 205 | 192 | $12K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 116 | 108 | $12K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 874 | 813 | $11K |
| 96127 | 1,661 | 1,525 | $6K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 137 | 127 | $5K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 63 | 54 | $2K |
| 83655 | 122 | 104 | $2K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 458 | 380 | $2K |
| 90686 | 1,763 | 1,587 | $1K | |
| 90651 | 15 | 15 | $737.10 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 57 | 48 | $442.92 |
| 96161 | 138 | 128 | $407.08 | |
| 90734 | 15 | 14 | $259.98 | |
| 90633 | 486 | 461 | $162.38 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 12 | 12 | $102.62 |
| 99173 | 683 | 666 | $65.00 | |
| 92551 | 439 | 429 | $48.00 | |
| 85018 | 148 | 142 | $35.34 | |
| 90680 | 997 | 900 | $0.00 | |
| 90716 | 344 | 329 | $0.00 | |
| 90723 | 1,168 | 1,060 | $0.00 | |
| 90647 | 1,209 | 1,086 | $0.00 | |
| 90696 | 15 | 14 | $0.00 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 17 | 12 | $0.00 |
| 90670 | 2,014 | 1,799 | $0.00 | |
| 90700 | 30 | 25 | $0.00 | |
| 90707 | 334 | 314 | $0.00 |